Amélia Vernochet

513 total citations
8 papers, 408 citations indexed

About

Amélia Vernochet is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Amélia Vernochet has authored 8 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Genetics. Recurrent topics in Amélia Vernochet's work include Renal Transplantation Outcomes and Treatments (3 papers), Mesenchymal stem cell research (3 papers) and Immune Cell Function and Interaction (3 papers). Amélia Vernochet is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Mesenchymal stem cell research (3 papers) and Immune Cell Function and Interaction (3 papers). Amélia Vernochet collaborates with scholars based in France, Italy and China. Amélia Vernochet's co-authors include Antoine Dürrbach, Bruno Azzarone, Massimo Giuliani, Noufϊssa Oudrhiri, Annelise Bennaceur‐Griscelli, Salem Chouaı̈b, Yé Fan, B. Mennesson, Estelle Oberlin and Denis Clay and has published in prestigious journals such as Blood, PLoS ONE and Kidney International.

In The Last Decade

Amélia Vernochet

8 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amélia Vernochet France	6	193	180	128	76	69	8	408
Chia-Lo Chang Taiwan	9	86 0.4×	119 0.7×	120 0.9×	39 0.5×	13 0.2×	9	377
Wei Nie China	10	93 0.5×	150 0.8×	133 1.0×	33 0.4×	11 0.2×	18	300
Jieqing Gao China	9	154 0.8×	102 0.6×	145 1.1×	68 0.9×	11 0.2×	13	371
Motoki Matsuki Japan	13	47 0.2×	128 0.7×	61 0.5×	34 0.4×	22 0.3×	30	401
Sukanya Suresh United States	11	106 0.5×	185 1.0×	37 0.3×	35 0.5×	10 0.1×	21	509
Sara Tezza United States	12	57 0.3×	147 0.8×	257 2.0×	231 3.0×	20 0.3×	17	647
Zhanhong Liu China	9	57 0.3×	169 0.9×	51 0.4×	124 1.6×	9 0.1×	14	369
Sarah E. B. Taylor United States	9	55 0.3×	216 1.2×	49 0.4×	29 0.4×	20 0.3×	9	438
Y Duan China	6	93 0.5×	131 0.7×	89 0.7×	14 0.2×	31 0.4×	14	334

Countries citing papers authored by Amélia Vernochet

Since Specialization

Citations

This map shows the geographic impact of Amélia Vernochet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélia Vernochet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélia Vernochet more than expected).

Fields of papers citing papers by Amélia Vernochet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélia Vernochet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélia Vernochet. The network helps show where Amélia Vernochet may publish in the future.

Co-authorship network of co-authors of Amélia Vernochet

This figure shows the co-authorship network connecting the top 25 collaborators of Amélia Vernochet. A scholar is included among the top collaborators of Amélia Vernochet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélia Vernochet. Amélia Vernochet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Pavec, Jérôme Le, Christophe Desterke, Olaf Mercier, et al.. (2023). mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4+CD57+ T Cells In Vivo and In Vitro. Pharmaceutics. 15(4). 1299–1299. 2 indexed citations

2.

Desterke, Christophe, et al.. (2021). The proliferation of belatacept-resistant T cells requires early IFNα pathway activation. American Journal of Transplantation. 22(2). 489–503. 4 indexed citations

3.

Zhang, Xiaomeng, et al.. (2020). CASK, the Soluble Glomerular Permeability Factor, Is Secreted by Macrophages in Patients With Recurrent Focal and Segmental Glomerulo—Sclerosis. Frontiers in Immunology. 11. 875–875. 10 indexed citations

4.

Fan, Yé, et al.. (2018). Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function. Stem Cells and Development. 28(1). 44–55. 83 indexed citations

5.

Lecru, Lola, Christophe Desterke, Stanislas Grassin‐Delyle, et al.. (2015). Cannabinoid receptor 1 is a major mediator of renal fibrosis. Kidney International. 88(1). 72–84. 100 indexed citations

6.

Giuliani, Massimo, et al.. (2011). Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation. PLoS ONE. 6(5). e19988–e19988. 70 indexed citations

7.

Giuliani, Massimo, Noufϊssa Oudrhiri, Amélia Vernochet, et al.. (2011). Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood. 118(12). 3254–3262. 126 indexed citations

8.

Ferlicot, Sophie, Amélia Vernochet, Serge Romana, et al.. (2009). Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells. Histopathology. 56(2). 188–197. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact